Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 12-2023 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 0 | 0 | 4,499,000 | 4,647,000 | 4,393,000 |
| Cost of Goods | 0 | N/A | 1,719,000 | 1,620,000 | 1,399,000 |
| Gross Profit | 0 | N/A | 2,780,000 | 3,027,000 | 2,994,000 |
| Operating Expenses | 0 | 0 | 2,424,000 | 2,489,000 | 2,297,000 |
| Operating Income | N/A | N/A | 356,000 | 538,000 | 697,000 |
| Other Income | 0 | 0 | 256,000 | 235,000 | 237,000 |
| Pre-tax Income | 0 | 0 | 612,000 | 773,000 | 934,000 |
| Income Tax | 0 | N/A | 97,000 | 102,000 | 129,000 |
| Net Income Continuous | 0 | N/A | 515,000 | 671,000 | 805,000 |
| Net Income | $0 | $N/A | $515,000 | $671,000 | $805,000 |
| EPS Basic Total Ops | N/A | N/A | 0.29 | 0.38 | 0.46 |
| EPS Basic Continuous Ops | N/A | N/A | 0.31 | 0.41 | 0.49 |
| EPS Diluted Total Ops | N/A | N/A | 0.29 | 0.38 | 0.47 |
| EPS Diluted Continuous Ops | N/A | N/A | 0.31 | 0.41 | 0.47 |
| EBITDA(a) | $N/A | $N/A | $703,000 | $824,000 | $993,000 |